Potential Effects and Dosage Control of Dimethyl Sulfoxide in Animal Experiments

What happens after dimethyl sulfoxide enters the animal body

In animal experiments, after dimethyl sulfoxide enters the body through routes such as injection, oral administration, or skin contact, it is absorbed and distributed to different tissues. It is generally believed that it is mainly metabolized by the liver, and the metabolites can be excreted from the body through urine and other routes. The speed of this process is affected by animal species, dose, and route of administration. General readers do not need to remember the detailed metabolic pathways; they only need to understand that dimethyl sulfoxide is not a substance that remains completely immobile locally. It may enter the bloodstream and affect multiple organs within a short period of time. Therefore, even if it is only used as a solvent, the amount used cannot be increased arbitrarily.

What physiological changes may occur

When dimethyl sulfoxide is used at high concentrations or large doses, it may cause some observable changes in animals. For example, local redness and swelling may occur at the injection site, and animals may briefly show reduced activity, respiratory changes, or slower weight gain. Some animals are relatively sensitive to the odor or skin irritation of dimethyl sulfoxide. It should be noted that these changes do not necessarily occur in every experiment, and the degree also varies with dose and animal model. Experimenters usually record these phenomena in detail in record sheets in order to determine whether the dosing regimen needs to be adjusted.

General approach to dose control

To reduce interference from dimethyl sulfoxide in experimental results, researchers usually follow the principle of "using the minimum effective amount." On the one hand, it must be sufficient to dissolve the drug so that the drug can enter the animal body at the set dose; on the other hand, its proportion in the final dosing solution cannot be too high. For experiments involving long-term administration or continuous observation, this principle is especially important. A common practice is to first fix the drug dose and then back-calculate the dilution factor of dimethyl sulfoxide; if the drug cannot be dissolved at the required dilution factor, consideration should be given to changing the solvent or adjusting the formulation method.

How to reduce interference caused by the solvent

Choose a solvent formulation that matches the route of administration as much as possible, and avoid directly using high-concentration dimethyl sulfoxide.

The dosing volume should be controlled within a range acceptable to the animal, avoiding injection of too much liquid at one time.

Before the formal experiment, a small-scale preliminary experiment can be conducted to observe the animal's tolerance to the solvent.

In experimental records, also note the solvent name, concentration, and dosing volume to facilitate subsequent analysis.

For general readers, dimethyl sulfoxide can be understood as a "carrier with side effects." While helping the drug enter the animal, it may also leave some traces itself. Good experimental design will, through dose control and control group setup, identify these traces as much as possible, thereby obtaining conclusions closer to the real situation.